150 related articles for article (PubMed ID: 27726016)
1. Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?
Verburg FA; Luster M; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):183-184. PubMed ID: 27726016
[No Abstract] [Full Text] [Related]
2. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
Clarke SE
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
[No Abstract] [Full Text] [Related]
3. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ
Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817
[No Abstract] [Full Text] [Related]
4. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
Dietlein M; Eschner W; Grünwald F; Lassmann M; Verburg FA; Luster M
Nuklearmedizin; 2016 Jun; 55(3):77-89. PubMed ID: 27350004
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for radioiodine therapy of differentiated thyroid cancer.
Luster M; Clarke SE; Dietlein M; Lassmann M; Lind P; Oyen WJ; Tennvall J; Bombardieri E;
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1941-59. PubMed ID: 18670773
[TBL] [Abstract][Full Text] [Related]
6. EANM procedure guidelines for therapy with iodine-131.
EANM
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP27-31. PubMed ID: 12723563
[No Abstract] [Full Text] [Related]
7. Inappropriate Use of Radioactive Iodine for Low-Risk Papillary Thyroid Cancer Is Most Common in Regions with Poor Access to Healthcare.
Marti JL; Davies L; Haymart MR; Roman BR; Tuttle RM; Morris LG
Thyroid; 2015 Jul; 25(7):865-6. PubMed ID: 25963001
[No Abstract] [Full Text] [Related]
8. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
Robbins RJ; Schlumberger MJ
J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
[TBL] [Abstract][Full Text] [Related]
9. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients.
Frangos S; Iakovou IP; Marlowe RJ; Eftychiou N; Patsali L; Vanezi A; Savva A; Mpalaris V; Giannoula EI
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):185-189. PubMed ID: 27557846
[TBL] [Abstract][Full Text] [Related]
10. Controversies, Consensus, and Collaboration in the Use of
Tuttle RM; Ahuja S; Avram AM; Bernet VJ; Bourguet P; Daniels GH; Dillehay G; Draganescu C; Flux G; Führer D; Giovanella L; Greenspan B; Luster M; Muylle K; Smit JWA; Van Nostrand D; Verburg FA; Hegedüs L
Thyroid; 2019 Apr; 29(4):461-470. PubMed ID: 30900516
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice.
Biermann M; Pixberg MK; Dörr U; Dietlein M; Schlemmer H; Grimm J; Zajic T; Nestle U; Ladner S; Sepehr-Rezai S; Rosenbaum S; Puskás C; Fostitsch P; Heinecke A; Schuck A; Willich N; Schmid KW; Dralle H; Schober O;
Nuklearmedizin; 2005; 44(6):229-34, 236-7. PubMed ID: 16400382
[TBL] [Abstract][Full Text] [Related]
12. Thyroid reports: insight into radioiodine ablation and new guidelines for nodule management.
J Nucl Med; 2006 Mar; 47(3):15N, 26N. PubMed ID: 16594104
[No Abstract] [Full Text] [Related]
13. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
Chebotareva ED; Shishkina VV
Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
[No Abstract] [Full Text] [Related]
14. [Der hoch-normale fT4-Spiegel ist mit Vorhofflimmern assoziiert. Neue Daten ergänzen die DGN-Handlungsempfehlung zur Radioiodtherapie].
Dietlein M; Drzezga A
Nuklearmedizin; 2016 Dec; 55(6):210-212. PubMed ID: 27922154
[No Abstract] [Full Text] [Related]
15. [The initial treatment of patients with differentiated thyroid carcinoma; consensus and controversies].
Smit JW
Ned Tijdschr Geneeskd; 2002 Mar; 146(10):454-7. PubMed ID: 11913107
[TBL] [Abstract][Full Text] [Related]
16. Differentiated thyroid carcinoma in a juvenile patient.
Khan MU; Nawaz MK; Saadullah M; Syed AA; Hussain R; Azhar R; Shah MA
Clin Nucl Med; 2008 May; 33(5):319-20. PubMed ID: 18431142
[TBL] [Abstract][Full Text] [Related]
17. Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
Tulchinsky M; Binse I; Campennì A; Dizdarevic S; Giovanella L; Jong I; Kairemo K; Kim CK
J Nucl Med; 2018 May; 59(5):723-725. PubMed ID: 29653977
[No Abstract] [Full Text] [Related]
18. [Surgery and follow-up 131I therapy in patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compliance with the 1987 consensus guidelines: additional data].
Kuijpens JL; Verheij CD; Haak HR; Ribot JG; Hoekstra OS; Coebergh JW
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1835-6. PubMed ID: 15495514
[TBL] [Abstract][Full Text] [Related]
19. Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.
Luster M; Musholt TJ
Nat Rev Endocrinol; 2013 Mar; 9(3):140-1. PubMed ID: 23183674
[No Abstract] [Full Text] [Related]
20. [Basic policy for postsurgical follow-up of patients with differentiated thyroid carcinoma--guidelines from abroad].
Hamada N
Nihon Rinsho; 2007 Nov; 65(11):2061-7. PubMed ID: 18018571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
